Pyoderma gangraenosum associated with autoimmune thyreopathy and hyperandrogenic syndrome

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 14, Issue 2, 2005, Pages 57-60

  Nečas, Miroslav ^a   Semrádová, Vera ^a   Vaškù, Vladimir ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Autoimmune thyreopathy; Management; Pyoderma gangraenosum

Indexed keywords

ALPHA2A INTERFERON; AMPICILLIN; ANTIBIOTIC AGENT; ANTITHYROID AGENT; AZATHIOPRINE; CARBIMAZOLE; CEFUROXIME; CHLORAMBUCIL; CIPROFLOXACIN; CLARITHROMYCIN; CLOFAZIMINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYPROTERONE ACETATE; DAPSONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROCAINE PENICILLIN; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERANDROGENISM; PYODERMA GANGRENOSUM; SEX DIFFERENCE; THYROIDECTOMY;

ADULT; ANTI-BACTERIAL AGENTS; ANTITHYROID AGENTS; BACTERIAL INFECTIONS; CARBIMAZOLE; FEMALE; GRAVES DISEASE; HUMANS; HYPERANDROGENISM; IMMUNOSUPPRESSIVE AGENTS; PYODERMA GANGRENOSUM; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 21744445082     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Fitzpatrick TB, Eisen AZ, Wolff K, et al. Pyoderma gangraenosum. Dermatology in General Medicine. McGraw-Hill; 1987. p. 1328-36.
2. Kashefsky H, Callahan E, Ruder UC, et al. Pyoderma Gangraenosum Involving the Foot. J Am Podiatr Med Assoc. 1999; 89(3): 137-40.
3. Kilian J, Pizinger K. Pyoderma gangraenosum. Čs Derm 1997, 72 (5): 198-201.
4. Müller M, Vaškù V, Semrádová V. Pyoderma gangraenosum in a patient with a chronic lymphatic leukemia and prostatic carcinoma. Čs Derm 1999; 74(6): 249-52.
5. Powel FC, Su WPD, Perry HO. Pyoderma gangraenosum: Classification and management. JAAD 1996; 34: 395-409.
6. Lachapelle JM, Marot L, Jablonska S. Superficial granulomatous pyoderma gangraenosum of the face, successfully treated by cyclosporine: A long-term follow-up. Dermatology 2001; 202: 155-7.
7. Blitz NM, Rudikoff D. Pyoderma gangraenosum. Mt Sinai J Med 2001 Sep-Oct; 68 (4-5): 287-97.
8. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
9. Jarčušková D, Benečová K, Ficová M, et al. Pyoderma gangraenosum-clinical aspects, management. Čs Derm 2002; 77(2): 80-3.
10. Huish SB, De la Paz EM, Ellis PR, et al. Pyoderma Gangraenosum of the Hand: A Case Series and Review of the Literature. J Hand Surg 2001; 26(4): 679-85.
11. Masarovičová A. Current possibilities of local and systemic treatment of pyoderma gangraenosum. Čs Derm 1996; 71(2): 72-4.
12. Mokni M, Philips T. Management of pyoderma gangraenosum. Hosp Pract (Off Ed). 2001 Apr 15; 36(4): 40-4.